Aesthetic Technologies
Regulation Crowdfunding offering on Netcapital
$81,420
of $1.07M goal
7.6% funded
About the offering
A Breakthrough in All-Natural Dermal Filler Technology. A 100% natural, biodegradable, and moldable solution is now available for correcting wrinkles. Made from a highly purified agarose gel, Algeness® is an injectable implant that provides immediate volumizing to the face, for a younger appearance. Safe and chemical free, Algeness® is fulfilling the expectations of even the most demanding practitioners. The Problem - As we age, we lose the volume in our face that makes our skin look soft and youthful. Dermal fillers, which can temporarily erase lines and wrinkles, are increasingly popular. However, all dermal fillers are not the same; competing products, such as Hyaluronic Acid (HA), contain chemicals that can cause harmful side effects. This is why both patients and the medical community have been searching for a more natural solution. Algeness®: The Anti-Aging Solution - Created by Advanced Aesthetics Technologies, Algeness® fulfills patients’ demands for better and safer products to enhance and improve their appearance and sense of well-being. Our product is a 100% natural, biodegradable, and injectable gel implant—the culmination of 10 years of scientific and clinical research. We have received government approvals in the EU and elsewhere, and Algeness® is now being used to treat patients in 27 countries across Europe, Asia, Latin America, and the Middle East. Algeness®: Competitive Advantages: 100% biodegradable, fully biocompatible and non-allergenic, offering excellent tolerability for patients, with minimal irritation. Free of solvents and synthetic chemicals. Volumizing effects immediately visible, allowing medical practitioners and patients to evaluate the result of the injection immediately after the procedure, compared to the 2-4 weeks required to see the final results of Hyaluronic Acid fillers. Exhibits low level of migration - the product stays where it has been injected. Typically requires only one visit, compared to multiple visits required for competing fillers. Long lasting results of over 12 months, proven by clinical studies
FAQ
How much has Aesthetic Technologies raised?
Aesthetic Technologies has raised $81,420 of a $1.07M goal.
Where is Aesthetic Technologies's campaign listed?
The offering is listed on Netcapital, an SEC-registered Reg CF intermediary.
What are the terms of Aesthetic Technologies's raise?
Common Stock, $19.13M cap, $2.50/share.
When does Aesthetic Technologies's offering close?
The stated close date is Mar 15, 2019.
